Top 5 Approved Drugs for Breast Cancer Management

Discover the top five FDA-approved medications used in breast cancer treatment. This article covers targeted therapies like Afinitor, Piqray, Nerlynx, Kisqali, and Ibrance, explaining their functions and usage. Early detection and personalized treatment are crucial, so consulting healthcare providers is essential for optimal management of breast cancer. Stay informed about the latest approved therapies to understand options available for effective treatment and improved outcomes.

Breast cancer is one of the most frequently diagnosed cancers worldwide, primarily affecting women but also occurring in men. It originates from abnormal growth of breast cells, with genetic and environmental factors playing a role. Early detection via mammograms and physical exams is vital, especially when symptoms like lumps, skin changes, or nipple issues appear. Treatment options often include targeted therapies and medications, such as:

Afinitor®
Also known as Afinitor Disperz, this therapy blocks cancer cell growth, delaying disease progression. It’s also used for certain kidney, brain, pancreatic, and gastrointestinal tumors, as well as specific tuberous sclerosis-related tumors.

Piqray®
Also named Alpelisib, Piqray interrupts the PI3K pathway, depriving cancer cells of energy. It’s indicated for hormone receptor-positive, HER2-negative metastatic breast cancer with PIK3CA mutations in postmenopausal women and men.

Nerlynx®
Featuring neratinib, this medication is approved for early-stage HER2-positive breast cancer after surgery. It helps reduce recurrence by inhibiting tumor growth, especially in women previously treated with trastuzumab.

Kisqali®
Known as ribociclib, Kisqali targets proteins involved in cell growth. It is used alongside hormone therapy for advanced hormone receptor-positive, HER2-negative breast cancer in postmenopausal women without prior treatment.

Ibrance®
Also called palbociclib, Ibrance is prescribed for metastatic ER-positive, HER2-negative breast cancer, mainly in postmenopausal women. It works by blocking enzymes essential for cancer cell multiplication.

Always consult healthcare professionals for medical advice. This article is for informational purposes only.